A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients
{{output}}
Background: Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these pa... ...
